Bupropion alone is not licensed for weight management, although a combination product with naltrexone is approved for obesity. Any off-label use for weight loss should be discussed with a prescriber, considering the risk-benefit profile.
Bupropion is classified as a Category B drug in the UK, meaning animal studies have not shown risk but adequate human studies are lacking. It should only be used during pregnancy if the potential benefit outweighs the possible risk to the fetus, after thorough medical review.
Unlike selective serotonin reuptake inhibitors (SSRIs) that increase serotonin, bupropion primarily raises norepinephrine and dopamine levels. This distinct mechanism often results in a lower incidence of sexual side effects and less weight gain compared with many SSRIs.
Take the dose early in the morning and avoid evening dosing. If insomnia persists, discuss with a prescriber; a dose reduction or switch to a different antidepressant may be considered.
Alcohol can lower the seizure threshold and increase the risk of side effects. It is advisable to limit or avoid alcohol, especially during the initial weeks of therapy.
When used for smoking cessation, the usual course is 7-12 weeks. Many people notice reduced cravings within the first two weeks, but optimal results are achieved with a full treatment duration and behavioural support.
Typical signs include loss of consciousness, rhythmic jerking movements, or sudden collapse. If any of these occur, seek emergency medical care immediately.
Bupropion is not commonly screened for in standard workplace or sports drug tests. However, specialized testing can detect its presence if specifically requested.
Take the missed dose as soon as you remember, unless it is less than 12 hours before the next scheduled dose. In that case, skip the missed dose and continue with your regular schedule-do not double up.
Bupropion can cause modest increases in blood pressure, particularly at higher doses or in individuals with pre-existing hypertension. Regular monitoring is recommended, and dose adjustment or switching medication may be needed if pressures remain elevated.
Bupropion is an atypical antidepressant that also helps people stop smoking. In the United Kingdom it is a prescription-only (POM) medication, available as a 150 mg pill. It is marketed under several brand names, most notably Wellbutrin (for depression) and Zyban (for smoking cessation). The active ingredient is bupropion hydrochloride, and it belongs to the therapeutic class of antidepressants, addiction & quit-smoking agents.
Bupropion’s primary action is to inhibit the re-uptake of the neurotransmitters norepinephrine and dopamine. By blocking the transporters that normally remove these chemicals from the synaptic gap, bupropion increases their concentration in the brain, which can improve mood and reduce cravings.
In addition, bupropion acts as a non-competitive antagonist at nicotinic acetylcholine receptors. This reduces the rewarding effect of nicotine, helping smokers experience fewer withdrawal symptoms when they quit.
Key pharmacokinetic points
These indications are approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA). The medication is prescribed when a clinician judges that the benefits outweigh the risks for the individual patient.
Research has explored several off-label applications for bupropion. None are approved by the MHRA, and any use outside the licensed indications should be supervised by a qualified healthcare professional.
Off-label use requires medical supervision and individualized risk assessment.
This article provides educational information about bupropion and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
